Loading...
Loading...
Novo Nordisk A/S · Pharmaceuticals
Mega Cap
Novo Nordisk A/S's TraderMatrix Quality Score is 79/100 (Solid), a 0–100 read on profitability, valuation, balance-sheet safety, growth and (for dividend payers) payout safety. Novo Nordisk A/S is a Pharmaceuticals company in the mega cap tier.
NVO ranks #2 of 13 in the Pharmaceuticals sector by Quality Score. Closest scores:
Quality Score is a 0–100 composite rating blending profitability, valuation, balance-sheet safety, growth and (for dividend payers) payout safety. Higher scores indicate stronger fundamental characteristics. Use it to screen out weak names before selling premium or buying LEAPS. Read the full methodology.
Novo Nordisk A/S has a TraderMatrix Quality Score of 79/100, which falls in the "Solid" band. It ranks #2 of 13 in the Pharmaceuticals sector. Scores of 80+ are rated High quality, 65–79 Solid, 50–64 Mixed and below 50 Weak. This is a fundamentals read, not investment advice.
The Quality Score is a 0–100 composite that blends profitability, valuation, balance-sheet safety, growth and (for dividend payers) payout safety into one number. NVO's current score is 79/100.
The score is recalculated as new data arrives. NVO's score of 79/100 was last updated on Sep 25, 2026.
Updated Sep 25, 2026